The world’s first malaria vaccine has been given the go ahead by European regulators. This could protect millions of children in sub-Saharan Africa from the life-threatening disease.

The shot has been developed by UK health care company GlaxoSmithKline, with part funding from the Bill and Melinda Gates Foundation. The European Medicines Agency recommended that the drug should be licenced for use in young children in Africa who are at risk of catching the disease.

Read more